Palatin Technologies Inc
NYSEAM:PTN
United States / Healthcare / Biotechnology
Exchange Data
Hide this widget
Price
0.19 USD
Day change
0.03 (15.39%)
52-week range
0.16 - 2.48
20:59 - Closed
Pre Market0.17 -0.02 (-9.82%)
Summary of Palatin Technologies Inc
Hide this widget
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
-0.62 (-76.50%)
Data Explorer
Hide this widget
Search metric that you want to observe. Create your own widget, customise and rearrange metrics
| Metric Name | Value | Trend |
|---|---|---|
| Dividend Yield | 0.0% | |
| P/E Ratio | -0.2x | |
| Revenue | 350 K | |
| Net Income to Company | - |
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| PTN | Peers | Sector | |
|---|---|---|---|
Market Cap | 4.952 M | 145.4 M | 62.3 M |
Price % of 52 Week High | Premium | 49.3% | 59.3% |
Dividend Yield | 0.0% | 0.0% | 0.0% |
Shareholder Yield | Premium | -13.6% | -0.7% |
1 Year Price Total Return | -89.5% | -47.2% | -14.9% |
Beta (5 Year) | 0.90 | 1.33 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Palatin is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for Palatin Technologies Inc
Model Gallery
Hide this widget
| DuPont ROE AnalysisView Updated 11 hours ago |
| Earnings Power ValueView Updated 1 day ago |
| 10Y Historical FinancialsView Updated 11 hours ago |
| 5Y Historical FinancialsView Updated 11 hours ago |
| CAPM WACC ModelView Updated 14 hours ago |
| 10Y DCF EBITDA ExitView Updated 5 days ago |
| 10Y DCF Revenue ExitView Updated 5 days ago |
| 10Y DCF Growth ExitView Updated 5 days ago |
| 5Y DCF EBITDA ExitView Updated 5 days ago |
| 5Y DCF Revenue ExitView Updated 5 days ago |
| 5Y DCF Growth ExitView Updated 5 days ago |
| EV / EBIT MultiplesView Updated 1 day ago |
| EV / EBITDA MultiplesView Updated 1 day ago |
| P/E MultiplesView Updated 1 day ago |
| Price / Book MultiplesView Updated 1 day ago |
| Price / Sales MultiplesView Updated 1 day ago |
| EV / Revenue MultiplesView Updated 1 day ago |
Historical Financials
Full Financials
Hide this widget
| (USD in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Jun-23 | Jun-24 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 4.85 | 4.49 | 0.35 | 2.03 | |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | (33) | (30) | (30) | (6.57) | (5.04) |
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 1.05 | 0.59 | 0.36 | 0.82 | 0.36 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | (30) | (32) | (27) | (11) | (4.85) |
Analyst Notes
April 15, 2025
Hide this widget